Tandem Diabetes Care, Inc. Increase Decrease In Operating Lease Liability
Tandem Diabetes Care, Inc. (TNDM) reported Increase Decrease In Operating Lease Liability of $4.09 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-06
- Tandem Diabetes Care, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$3.80M, a 211.51% decline year-over-year.
- Tandem Diabetes Care, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was $7.89M, a 57.90% increase year-over-year.
- Tandem Diabetes Care, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was $10.21M, a 4.59% decline year-over-year.
- Tandem Diabetes Care, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was $614.00K, a 79.05% decline year-over-year.
- Tandem Diabetes Care, Inc. increase decrease in operating lease liability for fiscal 2025 was $19.23M, a 9.25% increase from fiscal 2024.
- Tandem Diabetes Care, Inc. increase decrease in operating lease liability for fiscal 2024 was $17.60M, a 309.04% increase from fiscal 2023.
- Tandem Diabetes Care, Inc. increase decrease in operating lease liability for fiscal 2023 was $4.30M, a 83.09% decline from fiscal 2022.
- Tandem Diabetes Care, Inc. increase decrease in operating lease liability for fiscal 2022 was $25.45M, a 309.28% increase from fiscal 2021.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $4.09M 10-Q · filed 2026-08-06 | $14.30M derived: sum of 3 quarters · filed 2026-08-06 | $14.92M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $7.89M 10-Q · filed 2026-05-07 | $18.10M derived: sum of 2 quarters · filed 2026-05-07 | $18.71M derived: sum of 3 quarters · filed 2026-05-07 | $22.12M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $10.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $10.82M derived: sum of 2 quarters · filed 2026-02-19 | $14.23M derived: sum of 3 quarters · filed 2026-08-06 | $19.23M 10-K · filed 2026-02-19 |
| 2025-09-30 | $614.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $4.02M derived: sum of 2 quarters · filed 2026-08-06 | $9.02M 10-Q · filed 2025-11-06 | $19.72M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $3.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $8.40M 10-Q · filed 2026-08-06 | $19.10M derived: sum of 3 quarters · filed 2026-08-06 | $22.03M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $5.00M 10-Q · filed 2026-05-07 | $15.70M derived: sum of 2 quarters · filed 2026-05-07 | $18.63M derived: sum of 3 quarters · filed 2026-05-07 | $21.71M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $10.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $13.63M derived: sum of 2 quarters · filed 2026-02-19 | $16.71M derived: sum of 3 quarters · filed 2026-02-19 | $17.60M 10-K · filed 2026-02-19 |
| 2024-09-30 | $2.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $6.01M derived: sum of 2 quarters · filed 2025-11-06 | $6.90M 10-Q · filed 2025-11-06 | $455.00K derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $3.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $3.97M 10-Q · filed 2025-08-06 | -$2.48M derived: sum of 3 quarters · filed 2026-02-19 | $3.25M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $883.00K 10-Q · filed 2025-04-30 | -$5.56M derived: sum of 2 quarters · filed 2026-02-19 | $162.00K derived: sum of 3 quarters · filed 2026-02-19 | $2.29M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | -$6.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$721.00K derived: sum of 2 quarters · filed 2026-02-19 | $1.41M derived: sum of 3 quarters · filed 2026-02-19 | $4.30M 10-K · filed 2026-02-19 |
| 2023-09-30 | $5.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $7.85M derived: sum of 2 quarters · filed 2024-11-06 | $10.74M 10-Q · filed 2024-11-06 | $11.88M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $2.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $5.02M 10-Q · filed 2024-08-01 | $6.16M derived: sum of 3 quarters · filed 2025-02-26 | $23.02M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $2.90M 10-Q · filed 2024-05-02 | $4.04M derived: sum of 2 quarters · filed 2025-02-26 | $20.90M derived: sum of 3 quarters · filed 2025-02-26 | $29.45M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $18.00M derived: sum of 2 quarters · filed 2025-02-26 | $26.55M derived: sum of 3 quarters · filed 2025-02-26 | $25.45M 10-K · filed 2025-02-26 |
| 2022-09-30 | $16.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $25.41M derived: sum of 2 quarters · filed 2023-11-01 | $24.30M 10-Q · filed 2023-11-01 | $26.96M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $8.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $7.44M 10-Q · filed 2023-08-03 | $10.10M derived: sum of 3 quarters · filed 2024-02-21 | $12.49M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | -$1.11M 10-Q · filed 2023-05-03 | $1.55M derived: sum of 2 quarters · filed 2024-02-21 | $3.94M derived: sum of 3 quarters · filed 2024-02-21 | $4.02M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $2.66M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $5.05M derived: sum of 2 quarters · filed 2024-02-21 | $5.12M derived: sum of 3 quarters · filed 2024-02-21 | $6.22M 10-K · filed 2024-02-21 |
| 2021-09-30 | $2.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $2.47M derived: sum of 2 quarters · filed 2022-11-02 | $3.56M 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $76.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $1.17M 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | $1.09M 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | $5.79M 10-K · filed 2023-02-22 | |||
| 2019-12-31 | $4.22M 10-K · filed 2022-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |